Disturbed shear stress promotes atherosclerosis through TRIM21-regulated MAPK6 degradation and consequent endothelial inflammation

IF 7.9 1区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL
Feng Wang, Shu-Yu Wang, Yue Gu, Shuai Luo, Ai-Qun Chen, Chao-Hua Kong, Wen-Ying Zhou, Li-Guo Wang, Zhi-Mei Wang, Guang-Feng Zuo, Xiao-Fei Gao, Jun-Jie Zhang, Shao-Liang Chen
{"title":"Disturbed shear stress promotes atherosclerosis through TRIM21-regulated MAPK6 degradation and consequent endothelial inflammation","authors":"Feng Wang,&nbsp;Shu-Yu Wang,&nbsp;Yue Gu,&nbsp;Shuai Luo,&nbsp;Ai-Qun Chen,&nbsp;Chao-Hua Kong,&nbsp;Wen-Ying Zhou,&nbsp;Li-Guo Wang,&nbsp;Zhi-Mei Wang,&nbsp;Guang-Feng Zuo,&nbsp;Xiao-Fei Gao,&nbsp;Jun-Jie Zhang,&nbsp;Shao-Liang Chen","doi":"10.1002/ctm2.70168","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Rationale</h3>\n \n <p>Coronary artery plaques often develop in regions subjected to disturbed shear stress (DSS), yet the mechanisms underlying this phenomenon remain poorly understood. Our study aimed to elucidate the unknown role of MAPK6 in shear stress and plaque formation.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>In vitro and in vivo experiments, RNA-seq, CO-IP and proteomic analysis, combined with single-cell RNA-seq datasets were used to reveal the upstream and downstream mechanisms involved. AAV-MAPK6, ApoE<sup>−/−</sup>MAPK6<sup>flox/flox</sup>TEK<sup>Cre</sup> mice and the CXCL12 neutraligand were used to confirm the beneficial effects of MAPK6 against atherosclerosis.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Our study revealed a substantial decrease in MAPK6 protein levels in endothelial cells in response to DSS, both in vivo and in vitro, which was contingent on the binding of the ubiquitin ligase TRIM21 to MAPK6. Endothelium-specific MAPK6 overexpression exerts antiatherosclerotic effects in ApoE<sup>−/−</sup> mice, elucidating the unexplored role of MAPK6 in atherosclerosis. Comprehensive RNA-seq, integrated single-cell mapping and further experiments unveiled the involvement of MAPK6 in inflammation through the EGR1/CXCL12 axis. ApoE<sup>−/−</sup>MAPK6<sup>flox/flox</sup>TEK<sup>Cre</sup> mice finally confirmed that conditional MAPK6 knockout resulted in endothelial inflammation and significant increases in plaque areas. Notably, these effects could be reversed through the neutralization of CXCL12.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Our study illuminates the advantages of MAPK6 in decelerating plaque progression, highlighting the potential of safeguarding MAPK6 as a novel therapeutic strategy against atherosclerosis.</p>\n </section>\n \n <section>\n \n <h3> Key points</h3>\n \n <div>\n <ul>\n \n <li>Disturbed flow activates the ubiquitin‒proteasome degradation pathway of MAPK6 in endothelial cells, which is contingent on the binding of the ubiquitin ligase TRIM21 to MAPK6.</li>\n \n <li>Endothelial MAPK6 has an advantageous impact on decelerating plaque progression.</li>\n \n <li>MAPK6 regulates endothelial inflammation via the EGR1/CXCL12 axis.</li>\n </ul>\n </div>\n </section>\n </div>","PeriodicalId":10189,"journal":{"name":"Clinical and Translational Medicine","volume":"15 1","pages":""},"PeriodicalIF":7.9000,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11705438/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Translational Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ctm2.70168","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Rationale

Coronary artery plaques often develop in regions subjected to disturbed shear stress (DSS), yet the mechanisms underlying this phenomenon remain poorly understood. Our study aimed to elucidate the unknown role of MAPK6 in shear stress and plaque formation.

Methods

In vitro and in vivo experiments, RNA-seq, CO-IP and proteomic analysis, combined with single-cell RNA-seq datasets were used to reveal the upstream and downstream mechanisms involved. AAV-MAPK6, ApoE−/−MAPK6flox/floxTEKCre mice and the CXCL12 neutraligand were used to confirm the beneficial effects of MAPK6 against atherosclerosis.

Results

Our study revealed a substantial decrease in MAPK6 protein levels in endothelial cells in response to DSS, both in vivo and in vitro, which was contingent on the binding of the ubiquitin ligase TRIM21 to MAPK6. Endothelium-specific MAPK6 overexpression exerts antiatherosclerotic effects in ApoE−/− mice, elucidating the unexplored role of MAPK6 in atherosclerosis. Comprehensive RNA-seq, integrated single-cell mapping and further experiments unveiled the involvement of MAPK6 in inflammation through the EGR1/CXCL12 axis. ApoE−/−MAPK6flox/floxTEKCre mice finally confirmed that conditional MAPK6 knockout resulted in endothelial inflammation and significant increases in plaque areas. Notably, these effects could be reversed through the neutralization of CXCL12.

Conclusions

Our study illuminates the advantages of MAPK6 in decelerating plaque progression, highlighting the potential of safeguarding MAPK6 as a novel therapeutic strategy against atherosclerosis.

Key points

  • Disturbed flow activates the ubiquitin‒proteasome degradation pathway of MAPK6 in endothelial cells, which is contingent on the binding of the ubiquitin ligase TRIM21 to MAPK6.
  • Endothelial MAPK6 has an advantageous impact on decelerating plaque progression.
  • MAPK6 regulates endothelial inflammation via the EGR1/CXCL12 axis.

Abstract Image

受干扰的剪切应力通过trim21调控的MAPK6降解和随之而来的内皮炎症促进动脉粥样硬化。
理由:冠状动脉斑块通常发生在受干扰剪切应力(DSS)影响的区域,但这一现象的机制尚不清楚。我们的研究旨在阐明MAPK6在剪切应力和斑块形成中的未知作用。方法:采用体外和体内实验,结合单细胞RNA-seq数据集,采用RNA-seq、CO-IP和蛋白质组学分析,揭示其上下游机制。用AAV-MAPK6、ApoE-/- mapk6flox /floxTEKCre小鼠和CXCL12中性配体证实MAPK6对动脉粥样硬化的有益作用。结果:我们的研究揭示了内皮细胞中MAPK6蛋白水平在体内和体外对DSS的反应中显著下降,这取决于泛素连接酶TRIM21与MAPK6的结合。内皮特异性MAPK6过表达在ApoE-/-小鼠中发挥抗动脉粥样硬化作用,阐明了MAPK6在动脉粥样硬化中的未被探索的作用。综合RNA-seq,综合单细胞定位和进一步的实验揭示了MAPK6通过EGR1/CXCL12轴参与炎症。ApoE-/- mapk6flox /floxTEKCre小鼠最终证实,条件性MAPK6基因敲除导致内皮炎症和斑块面积显著增加。值得注意的是,这些影响可以通过中和CXCL12来逆转。结论:我们的研究阐明了MAPK6在减缓斑块进展方面的优势,强调了保护MAPK6作为对抗动脉粥样硬化的新治疗策略的潜力。关键点:血流紊乱激活内皮细胞中MAPK6的泛素-蛋白酶体降解途径,这取决于泛素连接酶TRIM21与MAPK6的结合。内皮细胞MAPK6对减缓斑块进展具有有利影响。MAPK6通过EGR1/CXCL12轴调控内皮炎症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
15.90
自引率
1.90%
发文量
450
审稿时长
4 weeks
期刊介绍: Clinical and Translational Medicine (CTM) is an international, peer-reviewed, open-access journal dedicated to accelerating the translation of preclinical research into clinical applications and fostering communication between basic and clinical scientists. It highlights the clinical potential and application of various fields including biotechnologies, biomaterials, bioengineering, biomarkers, molecular medicine, omics science, bioinformatics, immunology, molecular imaging, drug discovery, regulation, and health policy. With a focus on the bench-to-bedside approach, CTM prioritizes studies and clinical observations that generate hypotheses relevant to patients and diseases, guiding investigations in cellular and molecular medicine. The journal encourages submissions from clinicians, researchers, policymakers, and industry professionals.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信